Company intelligence / Profile preview

Daycrest

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Daycrest is a London-based private investment firm and family office focused on purpose-driven, entrepreneur-led growth companies. Founded by Ramez Sousou, the co-founder of TowerBrook Capital Partners, the firm invests permanent capital with a long-term perspective. Daycrest primarily targets early-stage and growth-stage opportunities across the healthcare, energy transition, and consumer sectors. Its healthcare portfolio includes investments in medical technology, digital health, diagnostics, and therapeutics, such as Hypervision Surgical, Curadel Pharma, and Saga Diagnostics.

Industry: Investors

Beyond the preview

Go deeper on Daycrest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daycrest.

Explore the full profile